Vol 12: Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.Reportar como inadecuado



 Vol 12: Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.


Vol 12: Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes. - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 12: Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.
This article is from BMC Medicine, volume 12.AbstractBackground: Hyperglycemia is associated with increased risk of all-site cancer that may be mediated through activation of the renin-angiotensin-system (RAS) and 3-hydroxy-3-methyl-glutaryl-coenzyme-A-reductase (HMGCR) pathways. We examined the joint associations of optimal glycemic control (HbA1c

Autor: Kong, Alice PS; Yang, Xilin; So, Wing-Yee; Luk, Andrea; Ma, Ronald CW; Ozaki, Risa; Cheung, Kitty KT; Lee, Heung-Man; Yu, Linda; Xu, Gang; Chow, Chun-

Fuente: https://archive.org/







Documentos relacionados